Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...

A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...

Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.

Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...

Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...

Dr. Carman Giacomantonio calls the first-in-human results from Sona Nanotech’s new therapy for patients with ...

Vilastobart in combination with atezolizumab continued to demonstrate a differentiated and generally well-tolerated safety profile. Treatment-related adverse events (AEs) were primarily Grade 1 or 2, ...

Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...